Human Reproduction Update, Vol.5, No.2 pp.94-102, 1999
© European Society of Human Reproduction and Embryology 1999; all rights reserved
Influence of human leukocyte antigen and tumour necrosis factor genes on the development of pre-eclampsia
Academic Unit, Department of Transfusion Medicine, 2 Forrest Road, Edinburgh EH1 2QN, UK
Abstract
Pre-eclampsia is a syndrome with a strong familial component. Autosomal recessive inheritance acting only in the mother is not consistent with the epidemiological data, and a more complex genetic susceptibility, involving interactions between maternal and fetal genomes, seems likely. The human leukocyte antigen (HLA) system has been implicated, but many of the findings reported have been inconsistent or contradictory. Pre-eclampsia is unlikely to be the simple result of excessive HLA-class II antigen sharing between mother and fetus, as was first thought, but a more complex mechanism involving feto-maternal compatibility cannot be excluded. The reported increase in HLA-DR4 in mothers and babies from pre-eclamptic pregnancies has not been independently confirmed for mothers, and no further studies have been conducted with babies. Consequently, the allegedly stronger relationship with HLA-DR4 sharing between mother and fetus has neither been confirmed nor refuted. Certain (B44-DR7)-containing haplotypes appear to confer increased risk for pre-eclampsia on the basis of independent analyses of American and Scottish populations. HLA-DR53 may be associated with the antiphospholipid antibody syndrome, which is itself a strong risk factor for pre-eclampsia. The tumour necrosis factor (TNF)-
allele, TNF1, may be associated with pre-eclampsia and certainly elevated concentrations of the cytokine appear to be a feature of the disease. The inducibility of TNF- is HLA-class-II dependent, and the relevance of HLA-class II genes might be entirely in relation to TNF- synthesis and secretion.
Keywords: HLA-DR/pre-eclampsia/pregnancy hypertension/tumour necrosis factor
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. F. Saftlas, H. Beydoun, and E. Triche Immunogenetic Determinants of Preeclampsia and Related Pregnancy Disorders: A Systematic Review Obstet. Gynecol., July 1, 2005; 106(1): 162 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hylenius, A.-M. Nybo Andersen, M. Melbye, and T. V. F. Hviid Association between HLA-G genotype and risk of pre-eclampsia: a case-control study using family triads Mol. Hum. Reprod., April 1, 2004; 10(4): 237 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Skomsvoll, V. Baste, L. M. Irgens, and M. Ostensen The Recurrence Risk of Adverse Outcome in the Second Pregnancy in Women With Rheumatic Disease Obstet. Gynecol., December 1, 2002; 100(6): 1196 - 1202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. A. Lachmeijer, J. B. A. Crusius, G. Pals, G. A. Dekker, R. Arngrimsson, and L. P. ten Kate Polymorphisms in the Tumor Necrosis Factor and Lymphotoxin-{alpha} Gene Region and Preeclampsia Obstet. Gynecol., October 1, 2001; 98(4): 612 - 619. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.C. Kilpatrick and K. Takakuwa HLA-DR4 and pre-eclampsia Hum. Reprod., November 1, 2000; 15(11): 2447 - 2447. [Full Text] [PDF]
|
|
|
|
|
|
K. HONDA, K. TAKAKUWA, I. HATAYA, M. YASUDA, T. KURABAYASHI, and K. TANAKA HLA-DQB1 and HLA-DPB1 Genotypes in Severe Preeclampsia Obstet. Gynecol., September 1, 2000; 96(3): 385 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. de Luca Brunori, L. Battini, M. Simonelli, F. Clemente, E. Brunori, M. L. Mariotti, and A. R. Genazzani Increased HLA-DR homozygosity associated with pre-eclampsia Hum. Reprod., August 1, 2000; 15(8): 1807 - 1812. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J VanWijk, K. Kublickiene, K. Boer, and E. VanBavel Vascular function in preeclampsia Cardiovasc Res, July 1, 2000; 47(1): 38 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Raghupathy, M. Makhseed, F. Azizieh, A. Omu, M. Gupta, and R. Farhat Cytokine production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion Hum. Reprod., March 1, 2000; 15(3): 713 - 718. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Takakuwa, K. Honda, K. Ishii, I. Hataya, M. Yasuda, and K. Tanaka Studies on the HLA-DRB1 genotypes in Japanese women with severe pre-eclampsia positive and negative for anticardiolipin antibody using a polymerase chain reaction-restriction fragment length polymorphism method Hum. Reprod., December 1, 1999; 14(12): 2980 - 2986. [Abstract] [Full Text] [PDF]
|
|